Status:
COMPLETED
Evaluating Parent Delivered Interventions for Children With Autism
Lead Sponsor:
Stanford University
Conditions:
Autistic Disorder
Developmental Disabilities
Eligibility:
All Genders
18-17 years
Phase:
NA
Brief Summary
The investigators will assess the efficacy of parent delivered interventions in the treatment of social and communication deficits in children with autism. By collecting information about parent and c...
Eligibility Criteria
Inclusion
- Inclusion Criteria for autism participants:
- Children between the ages of 1.6 and 17.11 years of age
- Males and females
- Diagnosis of autism based on DSM-IV-TR criteria, an expert clinical evaluation, and ADOS or ADI-R if needed
- Receiving or will receive a parent delivered intervention to alleviate symptoms related to their diagnosis of autistic disorder
- Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject
- Inclusion Criteria for developmentally delayed participants:
- Will have an age range between 1.6 and 17.11 years of age
- Males or females
- Diagnosis of a developmental delay or disorder based on DSM-IV-TR, ICD-10, and an expert clinical evaluation
- Have historical evidence of significant abnormal developmental milestones as determined by neurological history
- Receiving or will receive a parent delivered intervention
- Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject
- Exclusion Criteria for autism participants:
- Is medically unstable (e.g., more than one seizure a month)
- Have a medical diagnosis that causes autism like symptomology (e.g., Fragile X, Down syndrome, Angelman's syndrome, tuberous sclerosis, Rett's disorder)
- Exclusion Criteria for developmentally delayed subjects:
- Is medically unstable (e.g., more than one seizure a month)
- Has a diagnosis of ASD
Exclusion
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 18 2022
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT01882153
Start Date
February 1 2010
End Date
February 18 2022
Last Update
July 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305